Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023

$ 1499


Canada represents the world’s ninth biggest market for generic drugs in terms of value. Over the past few decades, the acceptance and use of generic drugs in Canada has changed significantly. The growth of the generic drug market in Canada has been catalysed by a number of factors. The continuous expiration of drug patents, rising aging population, increasing prevalence of chronic diseases and constant efforts by the government and health care service providers to control their healthcare expenditures have enabled generics to represent a multibillion dollar industry in Canada.

Canada Generic Drug Market Trends

The report entitled “Canada Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023” represents an in-depth analysis on the historical, current and future trends in the generic drug market in Canada. This research report serves as an exceptional tool to understand the drivers, sales trends, prescription trends, market structure, competitive landscape, regulations, key players, key drugs, manufacturing and the outlook of the generic drug Market in Canada. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who want to gain an insight into the Canadian generic drug market in any form.

Key Questions Answered in this Report:

  • What are generic drugs? How are they different from branded drugs?
  • How has the Canadian generic drug market performed in recent years?
  • How have generics performed compared to branded drugs?
  • What were the total sales and prescriptions for generic drugs in Canada?
  • Who are the key players in the Canadian generic drug market? How have they performed?
  • What is the structure of the generic drug market in Canada?
  • What is the pricing mechanism of generic drugs in Canada?
  • What is the value chain of generic drugs in Canada?
  • What are the regulations for generic drugs in Canada?
  • How are generic drugs distributed in Canada?
  • How are generic drugs manufactured?
  • What are the raw material and machinery requirements to manufacture generic drugs?
  • What are the drivers and challenges in the generic drug market in Canada?

1 Preface
2 Scope and Methodology
 
   2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Canada Generic Drug Market: Introduction

    4.1    What are Generics?
    4.2    Unbranded and Branded Generics
    4.3    Authorized Generics
    4.4    Specialty Generics
5    Why is the Generic Drug Market So Lucrative in Canada
    5.1    Blockbuster Drugs Facing Patent Expiration
    5.2    Substantial Price Difference Between Branded and Generic Drugs
    5.3    Government Incentives
    5.4    Savings for Drug Purchasers
    5.5    Biosimilars
    5.6    Ageing Population and Increasing Prevalence of Life Style Diseases 
6    Global Generic Drug Market
    6.1    Generic Drug Market Performance
        6.1.1    Value Trend
        6.1.2    Volume Trend 
    6.2    Market Breakup by Country
    6.3    Most Prescribed Generic and Branded Drugs
    6.4    Market Forecast
7    Canada Generic Drug Market
    7.1    Canada Pharmaceutical Market Performance     
        7.1.1 Value Trends
        7.1.2 Volume Trends 
        7.1.3 Market by Type
        7.1.4 Market Forecast 
    7.2    Canada Generic Drug Market Performance
        7.2.1    Value Trends 
        7.2.2    Volume Trends
        7.2.3    Market Forecast
8    SWOT Analysis
    8.1    Strengths
    8.2    Weaknesses
    8.3    Opportunities
    8.4    Threats
9    Value Chain Analysis
    9.1    Research and Development
    9.2    Manufacturing
    9.3    Marketing
    9.4    Distribution
10   Pricing Mechanism and Profit Margins at Various Levels of Supply Chain
11   Porter’s Five Forces Analysis
    11.1    Overview
    11.2    Bargaining Power of Buyers
    11.3    Bargaining Power of Suppliers
    11.4    Degree of Competition
    11.5    Threat of New Entrants
    11.6    Threat of Substitutes
12   Canada Generic Drug Market: Competitive Landscape
    12.1    Canada Generic Drug Market – Competitive Structure
    12.2    Canada Generic Drug Market – Sales Breakup of Key Players
    12.3    Canada Generics Distribution – Breakup by Channel
    12.4    Canada Generic Drug Market – Average Retail Price Per Prescription (Generic vs. Branded)
13    Canada Generic Drug Market: Key Success Factors
14    Canada Generic Drug Market: Road Blocks
15    Canada Generic Drug Market: Regulatory Framework

    15.1    Overview of Pharmaceutical Regulations
    15.2    Pre-Market Drug Submission Requirements for Generic Drugs
    15.3    Review Process for Generic Drugs
    15.4    Generic Drug Approval and Declaration of Its Bioequivalence
    15.5    Other Important Consideration
16    Generic Drug Manufacturing Process
    16.1    Manufacturing Process
    16.2    Raw Material Requirements
    16.3    Raw Materials Pictures
    16.4    Land and Construction Requirements 
    16.5    Machinery and Infrastructure Requirements
    16.6    Machinery Pictures
    16.7    Plant Layout
    16.8    Packaging Requirements 
    16.9    Utility Requirements 
    16.10 Manpower Requirements
17    Canada Generic Drug Market - Key Company Profiles

 
 

List of Figures

Figure 1: Structure of the Pharmaceutical Industry
Figure 2: Classification of Generic Drugs
Figure 3: Canada: Patent Expiry Exposure (in Billion US$)
Figure 4: Canada: Savings from Generic Drugs (in Billion US$), 2010-2017
Figure 5: Global: Generic Drug Market: Sales Value (in Billion US$), 2010-2017
Figure 6: Global: Generic Drug Market: Sales Volume (in Billion Units), 2010-2017
Figure 7: Global: Generic Drug Market: Sales Value Breakup by Country (in %), 2017
Figure 8: Global: Generic Drug Market: Sales Volume Breakup by Country (in %), 2017
Figure 9: Global: Generic Drug Market Forecast: Sales Value (in Billion US$), 2018-2023
Figure 10: Global: Generic Drug Market Forecast: Sales Volume (in Billion Units), 2018-2023
Figure 11: Global: Generic Drug Industry: SWOT Analysis
Figure 12: Global: Generic Drug Industry: Value Chain Analysis
Figure 13: Pricing Trends and Profit Margins at Various Levels of Supply Chain
Figure 14: Global: Generic Drug Industry: Porter’s Five Forces Analysis
Figure 15: Canada: Pharmaceutical Market: Sales Value (in Billion US$), 2011-2017
Figure 16: Canada: Pharmaceutical Market Forecast: Sales Value (in Billion US$), 2018-2023
Figure 17: Canada: Pharmaceutical Market: Sales Volume (in Million Prescriptions), 2010-2017
Figure 18: Canada: Pharmaceutical Market Forecast: Sales Volume (in Million Prescriptions), 2018-2023
Figure 19: Canada: Pharmaceutical Market: Sales Volume Breakup of Branded and Generic Drugs (in %), 2010 and 2017
Figure 20: Canada: Pharmaceutical Market Forecast: Sales Value Breakup of Branded and Generic Drugs (in %), 2010 and 2017
Figure 21: Canada: Generic Drug Market: Sales Value (in Billion US$), 2010-2017
Figure 22: Canada: Generic Drug Market Forecast: Sales Value (in Billion US$), 2018-2023
Figure 23: Canada: Generic Drug Market: Sales Volume (in Million Prescriptions), 2010-2017
Figure 24: Canada: Generic Drug Market Forecast: Sales Volume (in Million Prescriptions), 2018-2023
Figure 25: Canada: Generic Drug Market: Sales Breakup of Key Players (in %), 2017
Figure 26: Canada: Generic Drug Market: Average Retail Price Per Prescription (Generics vs. Branded- in US$ Per Prescription), 2010-2017
Figure 27: Canada: Generic Drug Market: Regulatory Framework for Generic Drugs
Figure 28: Generic Drug Manufacturing Plant: Detailed Process Flow 
Figure 29: Generic Drug Manufacturing Plant: Plant Layout 
Figure 30: Generic Drug Manufacturing Plant: Packaging Requirements

 

List of Tables
Table 1: Canada: Sales and Patent Expiry of Major Drugs Expected to Lose Patent Protection (in Billion US$)
Table 2: Global: Generic Drug Market: Sales Volume and Growth of Major Markets, 2017
Table 3: Global: Generic Drug Market: Volume Performance of Top Generic Drugs (in Million Prescriptions), 2017
Table 4: Global: Branded Drug Market: Volume Performance of Top Branded Drugs (in Million Prescriptions), 2017
Table 5: Canada: Distribution of Generic Drugs: Breakup by Channel (in %), 2017
Table 6: Generic Drug Manufacturing Plant: Raw Material Requirements 
Table 7: Generic Drug Manufacturing Plant: Land and Construction Requirements
Table 8: Generic Drug Manufacturing Plant: Machinery Requirements
Table 9: Generic Drug Manufacturing Plant: Utility Requirements
Table 10: Generic Drug Manufacturing Plant: Manpower Requirements


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Special Prices


    IMARC provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations
  • For more information, feel free to contact us.